Provided by Tiger Trade Technology Pte. Ltd.

HBM HOLDINGS-B

13.860
+0.3202.36%
Volume:9.94M
Turnover:138.86M
Market Cap:12.04B
PE:126
High:14.360
Open:13.580
Low:13.580
Close:13.540
52wk High:17.070
52wk Low:9.460
Shares:869.00M
HK Float Shares:869.00M
Volume Ratio:0.95
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.110
ROE:23.97%
ROA:10.88%
PB:3.67
PE(LYR):126.00
PS:8.57

Loading ...

HBM Holdings Restructures Board: Dr. Yiping Rong Steps Down, Mr. Youchen Chen and Dr. Ian Yi Liu Join as Executive Directors

Bulletin Express
·
Aug 27

HBM Holdings Files List of Directors, Board Committee Memberships and Disclosure-Responsible Management

Reuters
·
Aug 27

HBM Holdings-B (02142) Posts First-Half Profit of $64.85M, Down 11.16% Year-on-Year

Stock News
·
Aug 27

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

Press Release: Harbour BioMed Appoints Mr. Youchen Chen and Dr. Ian Y. Liu as Executive Directors

Dow Jones
·
Aug 27

HBM Holdings Names CFO Youchen Chen Executive Director Amid Board Changes

Reuters
·
Aug 27

Hbm Holdings - Yiping Rong Resigns as Executive Director Effective August 27, 2026

THOMSON REUTERS
·
Aug 27

Harbour Biomed Reports 2026 Interim Results: Three Integrated Growth Engines Accelerate Execution of Its Platform-Based Strategy

THOMSON REUTERS
·
Aug 27

Press Release: Harbour BioMed Reports 2026 Interim Results: Three Integrated Growth Engines Accelerate Execution of Its Platform-Based Strategy

Dow Jones
·
Aug 27

HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Reuters
·
Aug 27

Hbm Holdings H1 Revenue USD 122.5 Million

THOMSON REUTERS
·
Aug 27

Is HBM Holdings (SEHK:2142) Fully Valued After Its HBM7004 IND Approval?

Simply Wall St.
·
Aug 26

HBM Holdings to Join Hang Seng Composite Index

MT Newswires Live
·
Aug 24

HBM Holdings Added to Hang Seng Composite Index, Enabling Future Stock-Connect Eligibility

Bulletin Express
·
Aug 24

HBM Holdings Surges Nearly 15% as China Approves Clinical Trial Application for Late-Stage Solid Tumor Therapy

Stock News
·
Aug 20

HBM's Cancer Drug Candidate Gets China Approval

MT Newswires Live
·
Aug 18

HBM Holdings Secures NMPA Clearance for HBM7004 IND in Advanced Solid Tumors

Stock News
·
Aug 18

HBM Gets China NMPA Clearance to Start Hbm7004 Trial in Advanced Solid Tumors

Reuters
·
Aug 18

Hbm Holdings - Nmpa Approves Ind Application for Hbm7004 for Advanced Solid Tumors

THOMSON REUTERS
·
Aug 18

HBM Holdings Schedules 27 August 2026 Board Meeting to Approve 1H26 Results

Bulletin Express
·
Aug 17